Buspirone Hydrochloride Tablet
Product Images NDC 0615-8527

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 0615-8527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Buspirone 8527 1)

Structural Formula (Buspirone 8527 1)
Chemical structure of Buspirone Hydrochloride showing the molecular arrangement of its components, including a piperazine ring and other characteristic functional groups, consistent with the active ingredient Buspirone Hydrochloride.*
FDA Label Image

10 mg (one-third Of A Tablet) (Buspirone 8527 10)

10 mg (one-third Of A Tablet) (Buspirone 8527 10)
Buspirone Hydrochloride 30 mg tablet imprint. The image shows a white, square-shaped tablet with beveled edges and the number "10" imprinted on one side. No other markings or packaging are visible.*
FDA Label Image

Break Tablet 30 mg (Buspirone 8527 11)

Break Tablet 30 mg (Buspirone 8527 11)
Buspirone Hydrochloride 30 mg oral tablet shown held between two fingers. The white tablet is oblong and scored with the imprint '10 10 10' on one side. The image emphasizes the tablet's size and imprint, relevant to the human prescription drug by NCS HealthCare of KY, LLC dba Vangard Labs.*
FDA Label Image

Principal Display Panel (Buspirone 8527 12)

Principal Display Panel (Buspirone 8527 12)
Buspirone Hydrochloride Tablets USP 30 mg label for oral use in 30-count packaging. The label includes lot number and expiration date placeholders, barcode images, and storage instructions at 20° to 25°C. The product is labeled for institutional use only and is packaged by Vangard Labs, Glasgow, KY, with manufacture by Pliva Hrvatska for Teva (NDC 0093-5200-06). The label also features calendar markings for tracking doses.*
FDA Label Image

15 mg (the Entire Tablet) (Buspirone 8527 2)

15 mg (the Entire Tablet) (Buspirone 8527 2)
Buspirone Hydrochloride 30 mg oral tablet imprinted with "TV 1003" on one side and "555" on the other. The white, capsule-shaped tablet is manufactured by NCS HealthCare of KY, LLC dba Vangard Labs.*
FDA Label Image

10 mg (two-thirds Of A Tablet) (Buspirone 8527 3)

10 mg (two-thirds Of A Tablet) (Buspirone 8527 3)
Buspirone Hydrochloride 30 mg oral tablet imprinted with '5 5'. The tablet is white and scored, indicating it may be divided. Labeler is NCS HealthCare of KY, LLC dba Vangard Labs.*
FDA Label Image

7.5 mg (one-half Of A Tablet) (Buspirone 8527 4)

7.5 mg (one-half Of A Tablet) (Buspirone 8527 4)
Close-up image of the edge of a blister pack showing a single oral tablet slot labeled with the number 5. No further text or branding visible.*
FDA Label Image

5 mg (one-third Of A Tablet) (Buspirone 8527 5)

5 mg (one-third Of A Tablet) (Buspirone 8527 5)
Buspirone Hydrochloride 30 mg oral tablet imprinted with the number '5' on a white, square-shaped tablet. The image shows a close-up of a single tablet without any additional packaging or labeling visible.*
FDA Label Image

Break Tablet 15 mg (Buspirone 8527 6)

Break Tablet 15 mg (Buspirone 8527 6)
Buspirone Hydrochloride 30 mg oral tablet. The image shows a single white tablet imprinted with the numbers "5 5 5" held between two fingers. The tablet is square with rounded edges, consistent with a prescription drug tablet form by NCS HealthCare of KY, LLC dba Vangard Labs.*
FDA Label Image

30 mg (the Entire Tablet) (Buspirone 8527 7)

30 mg (the Entire Tablet) (Buspirone 8527 7)
Buspirone Hydrochloride 30 mg oral tablet showing a white, capsule-shaped pill with imprint 'TV 5200' on one side and '10 10 10' on the other side. This tablet is manufactured by NCS HealthCare of KY, LLC dba Vangard Labs.*
FDA Label Image

20 mg (two-thirds Of A Tablet) (Buspirone 8527 8)

20 mg (two-thirds Of A Tablet) (Buspirone 8527 8)
Buspirone Hydrochloride 30 mg oral tablets shown as two white, rectangular scored tablets with '10' imprinted on each half. The imprint is in black and split on either side of the score line for identification.*
FDA Label Image

15 mg (one-half Of A Tablet) (Buspirone 8527 9)

15 mg (one-half Of A Tablet) (Buspirone 8527 9)
Buspirone Hydrochloride 30 mg oral tablet depicted as a white, oval-shaped tablet scored with the number '10' imprinted on one side. No additional markings or packaging details are visible in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.